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Determination of Tissue Thromboplastin Activity
G.WIrNcunts and H.C. Hnurnn
Laboratory of Biochemistry, University of Utrecht, university centre 'De Uithof"
Utrecht; The Netherlands and the Gaubius Institute, Health Research Organization TNO,
Leiden, and Department of Biochemistry, State University Limburg, Maastricht
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Abstract. The one-stage prothrombin time test for tissue thromboplastin activity was
evaluated using the correction method. A strong influence ofthe intrinsic system was seen
depending on the clotting time and the type of tubes. This test was unsuitable for quanti-
tative comparison of thromboplastin activity of different preparations.
Subsequently a two-stage assay for human thromboplastin is described using purified
human factor vII, artificially prepared factor vII reagent, and a phospholipid suspension.
The correction method, applicated to this two-stage assay, resulted in a rectilinear dose-
response curve when the clotting times of a thromboplastin dilution series were plotted
against the reciprocal of the concentrations.
Using this test system it could be shown that thromboplastin from porcine tissue can
activate human factor VII quite well, while that from bovine tissue cannot.
Introduction
Assays for coagulation factors are based on measuring the coagulation
time of a test system in which the factor to be estimated is rate limiting. Since
coagulation is dependent upon a sequence ofreactions, all factors subsequent
to the one being measured must be kept constant or in excess for accurate
determinations. For this purpose,'plasma from patients with congenital
deficiencies or artificially depleted plasmas are used.
In principle, one might use normal plasma in an assay for human tissue
thromboplastin activity, because this activity does not occur in plasma' This
has been done in a great many studies but there are drawbacks to this meth-
od; for example, almost rectilinear plots have often been unjustly claimed
to be rectilinear without any theoretical basis and conclusions have been
based on this assumption. Ltrrrr and Ra,rNorF [1969] concluded from
Received: August 5, 1976; accepted by editor K.LncnNnn: November 20' 1976.
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various plots that no statistical method -could be found to compare the
activity of different thromboplastin preparations as used in routine tests. In
most studies, no attention has been given to the effect of the intrinsic system
on the assay and to the effect of the variable lipid content of the sample on
the prothrombinase formation. These influences were investigated in more
detail in our study. Application of the correction method [Hmmm. er a/.,
1965; Hnrrnrn and Mullen, 19681 showed that the effect of the intrinsic
system varied markedly depending on the clotting time, reflecting the tfrrom-
boplastin activity of the sample. The results of the one-stage protlrombin
time test can consequently lead to difficulties in the interpretation and to
ambiguous conclusions.
This study deals with a two-stage determination of human thrombo-
plastin activity using purified human factor VII and plasma artificiany de-
pleted of factor VII according to LBcnNrn and Dntnscn ll96n The suit-
ability of the assay system to thromboplastin preparations from some other
species was studied.
Materials and Methods
Human brain thromboplastin was prepared from acetonedried tissuc and purified as
described by Hncnr and OosrrnsanN-Vax Ln 11967l.
Porcine lung thromboplastrn was prepared according to the method d&lirresrr et al.
119421, with some modifications. Fresh lungs were washed with tapwater, ort into pieces
and homogenized in a Waring blender after the addition of saline (1Z) m{2m g tissue).
After a period of 3 h in an ice bath, large particles and connective tissrc urcre removed by
centrifugation at 1,250 g for 10 min. The supernatant was subjoded to tso $acessive
centrifugations at 2,500 g for 45 min and the pellets were discarded- Thrtmboplastin was
sedimented from the final supernatant at 100,000 B, for 60 min. The pdlet form€d a pink-
coloured lower layer, The upper layer containing most of the tlrombop,lastin artivity was
removed with a spatula and suspended in about one third of the original vohme of borate
buffer (I 0.15, pH 8.6) in a Potter-Elvehjem tube. This suspension was nrbjectcd to ultra-
centrifugation (100,000 g for 60 min) and resuspension in borate buffer fqrr times- It was
subsequently washed four times with distilled water. This resulted in a purified tftrombo-
plastin preparation which was free of soluble proteins. The greyoloured pellet was
lyophilized and stored at -20 "C.
Bovine brain thromboplastin prepared from fresh tissue as described by Owrrlr and
Ans [1951] was used.
Phospholipid suspension. A petroleum ether extract of acetone*ied human brain
tissue [Frscnnn and Hrcnr, 1934] was evaporated under reduced pr€$swe and the lipids
were dissolved in diethyl ether (1 ml/10 mg lipid). The solution obtained ms added drop-
wise to stirred veronal-acetate butrer (I 0.15, pH 7.4) tbroueh which nitrogen was blown.
The suspension, containing 1.0 mg lipid/ml, was stored in l-ml portiotrs in plastic tubes
at -20 "C.
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Normal platelet'poor plasma was obtained from human blood collected from a number
of healthy individuals into siliconized tubes containing one tenth of the blood volume of0.112 M sodium citrate by centrifugation at 15,000 g for 30 min. The plasma was storedin plastic tubes at 80 .C.
Factor vII reagent was prepared from fractions of human-citrated plasma and bovine-
oxalated plasma according to the modified method of Lrcnxnn and DsurscH [1967] asdescribed by Hnurrn et at. [19721.
Factor xwas measured using artificially depleted plasma prepared by the method ofHEMKIR et al.119721.
Human factor VII was purified by using several purification techniques as describedby Swanr [1971]. The initial fractions of the DEAE-cellulose column in the factor VII
reagent preparation were used as a source for factor VII. After adsorbtion to aluminium
hydroxide ('moist ge1', BDH) (0.5 % wlv) at 4 oc, the adsorbent was washed with 0.3 u
sodium EDTA, pH 8.0, and 0.1 u sodium citrate, pH g.0, folrowed by elution of factor vIIby 0.25 u phosphate buffer, pH g.0. The eluate was subjected to ammonium sulphateprecipitation. Factor vII was almost completely precipitated between 40 and, 6ol satu_
ration at 4'c. After centrifugation at 20,000 g for 60 min, the pellet was dissolved indistilled water and applied to a sephadex G-100 column (95 x 2.5 cm). The corumn was
eluted with 0.02 v phosphate buffer, pH 6.g, to which 0.1 rr,r Nacl had been added. Thefactor vII peak was situated just after a small peak containing factor X. The tiactions
were combined and diaryzed against veronal-chroride buffer (I 0.015, pH 7.35) for 1g h.The activity of the factor vII preparation was adjusted to 40.lof that of normal plasma.
The factor X activity of this preparation usually did not exceed 2l of that in normalplasma. The preparation was stored in l-ml portions in plastic tubes at -g0 "c.
one-stage prothrombin time test.-[o 0.1 ml of human platelet-poor plasma, 0.1 ml ofthromboplastin suspension was added. After 30 sec incubation at 37 .c, the mixture was
recalcified with 0.1 ml of 0.025 u calcium chloride and the time necessary for clotting was
measured with a chronometer. The test was performed in glass tubes as well as in poly-
sterol tubes. The effect ofphospholipids in this test was investigated by adding 0.r ml ofphospholipid suspension (0.3 mg/ml) to the plasma followed by 0.1 ml of thromboplastin
and recalcification with 0.1 ml of 0.033 v calcium chloride.
Two-stage assay of thromboprastin. Factor vII preparation (0.1 mr), thromboprastin
suspension (0'l ml) and 0.075 u cacl, solution (0.1 ml) were mixed and incubated for15 sec at 37 'C. Following this, 0. I ml of this mixture was added to a mixture of factor VII
reagent (0.1 ml) and phospholipid suspension (0.1 ml with optimal concentration) pre_
heated for about 30 sec at 37 "c and the clot formation was timed. Both stages were per_formed in glass tubes and the clotting was determined with a Kolle hook. The optimal
concentration of the phospholipid suspension was estimated in a similar two-stage assay,
except that the thromboprastin suspension was replaced by Russell viper venom (0.1 mg7
ml distilled water).
The correction method of Hrrrarun et al. for the assays of extrinsic coagulation factorspermits the calculation of the residual amount of an extrinsic factor in its test reagent by
using a one-stage procedure [H""*nn et at., 1g65; Hpurnn and Murrnn, 1g6g]. If a series
of known concentrations, c, of a factor is tested in a one-stage assay for that tactor, a
number of clotting times, t", is obtained. using buffer as a sample will give the buffer time,t6, of the test medium. If this buffer time is assumed to be due to an unknown but constant
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amount, L, of the rate-limiting factor in the reagent, and Michaelis-Menten kinetics apply,
then a rectilinear relationship should exist between (tr-t")/c and t". This is indeed found
with one-stage assays in the extrinsic system. This graph is known as the correction 
plot,
as thes lopeof thecurvea l lowstheexpress ionof thequant i t yL in thesameun i tsasc .
correction of c for L then produces a straight line relationship between t" and the inverse
of the total concentration of the coagulation factor. with the aid of this curve and the
clotting times of samples, the concentrations can be calculated more accurately than with
the plotting of c versus t" on double logarithmic paper'
Results
Application of the correction method described by Hnrrnnn and associates
[Hrurnneta l . ,1965;HnurBnandMULLER,1963] totheclot t ingt imesofa
series of dilutions of tissue thromboplastin in the one-stage prothrombin
time test performed in glass tubes did not result in a rectilinear correction
plot (fig. t, corv" A). So' besides the clotting initiated by the thromboplastin'
it 
"r. 
*u, an additional influence on the clotting process which varied
dependingontheclot t ingt ime. Inc lus ionofaddi t ionalphosphol ip idsoas
to prevent prothrombinase formation from being a possibly limiting step
at low thromboplastin concentrations had no effect on the observed non-
linearity (fig. 1, curve B). Replacement of the glass tubes by polysterol ones
resulted in a less curvilinear relation at least over a certain dose-response
range(flg.2).Additionofphospholipidtothesetubesalsoledtonoimprove-
ment. we concluded that the intrinsic system has a disturbing effect on the
est imat ionof thromboplast inact iv i ty in theone-Stageprothrombint ime
test. In a limited range, the correction plot can be used for practical pur-
poses; however, the value of L obtained should be interpreted with caution.
A series of dilutions of tissue thromboplastin in the two-stage assay at a
phospholipid concentration for optimal clotting (0'3 mg/mf) (fig'3) did
i"r,rti in a rectilinear correction plot (fig.4, curve A), indicating the occur-
renceofaconstantact iv i ty ,L, inaddi t iontothatof thromboplast in .This
ac t i v i t yo f t he tes tSys temwas found toco r respond to0 .038mg/m lo f t he
thromboplastinpreparationused.Plottingoftheclottingtimesagainstthe
reciprocalof thetota lconcentrat ion(TP*L)producedarect i l ineardose-
,"rponr" curve for this two-stage assay of tissue thromboplastin (fig'5'
curve A).
Plotting of clotting times versus thromboplastin concentrations on double
logarithmic paper resulted in a diagram which was approximately rectilinear
aScanbeshownbyastat is t ica lanalys is ' Inpract ice, th iscurvemaybeused
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Fig'L Correction plot for the ore-stage prothrombin time test with human platelet_poor plasma and porcine lung thromboplastin in glass tubes. curve A: 0.1 mr plasma,
0.1 mI thromboplastin and 0.r ml 0.025 rra calcium chloride; curve B: 0.I ml plasma,
0'1 ml phospholipid suspension, 0.1 mI thromboplastin and 0,1 ml 0.033 rn calcium
chloride.
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Fig'2. conection plot for the one-stage prothrombin time test with human pratelet_poor plasma and porcine lung thromboplastin in polysterol tubes. other conditions as infigure I
but then the inaccuracy in the determination of low thromboplastin activ-
ities is increased.
The usefulness of this test system in studies on thromboplastin prepara-
tions from other species was tested on porcine and bovine thromboprastin.
= L= 0.023 mg mt-1
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Flg'3.Influenceofthephospholipidconcentrationontheclottingofartificiallymade
factor VII deficient plasma by Russell viper venom'
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Fig.4'Correctionplottbrthetwo-stageassayofthromboplastinactivitywithpurified
human brain thromboplastin (A) and porcine lung thromboplastin (B)'
The results are given in figure 5, cuwes B .and C' Bovine brain thrombo-
;;;, highlv altive when tested with bovine plasma' 
demonstrated onlv a
small amount of activity, whereas porcine lung thromboplastin activated
human factor vII quite reasonably. By taking the activity of the homologous
human brain thromboplastin as 100 /,, the activity of the porcine prepala-
tion was 7 5 % andthat of the bovine preparation only 4 I on a weight basis'
These differences must be attributed to species specificity and to the actual
thromboplastin content of the preparations'
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Fig.S. The relationship between coagulation time (t") and concentration of thrombo-plastin in the two-stage assay after correction. 4 : purified human brain thromboplastin;
3 : purified porcine lung thromboplastin; c - bovine brain thromboolastin.
The elution pattern of porcine coagulation factors vII and II from
DEAE-cellulose differed from that of the human factors. consequenily, thepreparation of artificially deficient plasma from porcine and bovine plasma
according to the principle of LrcnNBn and D'urscn llglTj did, not succeed.
Discussion
The determination of thromboplastin activity is usually based on a com-parison of clotting times obtained by recalcification of normal citrated or
oxalated plasma in the presence of the tissue thromboplastin preparations.
Less attention has been given to the influence of the intrinsic palhway or ttre
effect of the varying amounts of phospholipid in the thromboplastin sampres
which function at the lipid-dependent stage of the coagulation mechanism.
Kinetic studies [Hnu*n et ar., 1965; Hrurnn and Mu'nn, 196g] madepossible the evaluation of this assay system. A very strong influence of the
intrinsic system was found when the test system was carried out in glass
tubes; it played a less pronounced role in polysteror tubes. Effects due to
d]]ution of the phospholipid in a series of dilutions of thromboplastin were
eliminated by adding a constant amount of phospholipid suspension to the
assay system. However, this inclusion did not result in an improvement of
the linearity of the dose-response curve. consequently, the determination of
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tissue thromboplastin should not be performed in a test system 
containing
normal plasma.
A two-stage assay for thromboplastin of bovine origin was developed 
by
NnrrasnsoN t196Sl. A comparable human system was possible 
only with the
puri f icat ionofhumanfactorsandtheavai labi l i tyofdef ic ientplasmas'
Using purified human factor VII' artificially prepared factor 
VII deficient
pf*ri" *A a phospholipid suspension (functional in prothrombinase forma-
tion), we developed a dependable two-stage assay for human thrombo-
plastin. Calculation of L, which accounts for small amounts 
of clot-pro-
moting activity in the reagents' from the tg.versus (tu-h)/trPl plot resulted
in a constant value tng'+)'This means that thromboplastin is the rate-
limiting factor which ls ireasor.d. correction of the series of thromboplastin
concentrations for L resulted in a rectiline ar diagtam of ts versus u([TP] +L)
with a slope which was suitable for reasonably accurate comparison 
of
thromboplastin activities (fig'5)' In addition' these results confirm the indi-
cation obtained fy ffEr'arsJand Mulr-Bn [1968] that tissue thromboplastin
behaves like the othercoagulation factors of the extrinsic system. 
variation
of the incubation time in ire first stage of this assay between 
15 and 60 sec
did not influence the clotting time' This suggests that no reaction 
took place
inthef irststageorthat i tw_ascompletedwithinl5sec'Accordingtoobser.
vations of Wlllraus and Nonms [1966] and NnvrensoN [1966]' a rapid reac-
tion is indeed Probable'
Equal amounts of porcine and bovine thromboplastin 
preparafions
revealed that the porcine preparation can activate human factor 
VII quite
well, while the bovine p'"pututio" cannot (fig'5)'This differing capacity of
thromboplastinpreparationstoactivatehumanfactorVllowingtospecies
specificity [QuIcr, 1941; Solpr'rt' l94l; MI'NN and HunN' 1952; Sron-
MoRKEN, 1957; lnslclnl- et al',1965] can be expressed more quantitatively
by using this test system' The inefficiency of bovine thromboplastin 
in the
act ivat ionofhumanfactorVl landitshighsensit iv i tytowardsact ivated
human factor VII [L.urn and Er'r'rNcseN' 1974] have been applied in the
estimation of human factor vII activated by incubation in the 
cold [Herrlrrn
et al . ,19761.
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